Singapore markets closed

IGM Biosciences, Inc. (IGMS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.41-0.72 (-8.86%)
At close: 04:00PM EDT
7.01 -0.40 (-5.39%)
Pre-market: 08:10AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-246,416
-246,416
-221,102
-165,164
-81,355
Depreciation & amortisation
8,277
8,277
6,075
4,484
1,025
Stock-based compensation
46,547
46,547
44,710
25,873
8,454
Change in working capital
-6,693
-6,693
155,170
6,447
2,045
Accounts payable
-992
-992
-3,002
652
2,198
Other working capital
-204,612
-204,612
-16,059
-138,226
-85,383
Other non-cash items
15,194
15,194
12,007
2,754
1,973
Net cash provided by operating activities
-192,231
-192,231
-5,853
-124,982
-67,881
Cash flows from investing activities
Investments in property, plant and equipment
-12,381
-12,381
-10,206
-13,244
-17,502
Purchases of investments
-365,039
-365,039
-540,022
-128,705
-207,986
Sales/maturities of investments
445,775
445,775
324,584
157,410
283,777
Net cash used for investing activities
68,355
68,355
-225,644
15,461
58,289
Cash flows from financing activities
Common stock issued
113,564
113,564
217,987
0
215,691
Common stock repurchased
-
-
-
-
0
Other financing activities
-
-
-
-1,555
-1,731
Net cash used provided by (used for) financing activities
115,068
115,068
219,382
2,476
214,781
Net change in cash
-8,808
-8,808
-12,115
-107,045
205,189
Cash at beginning of period
121,920
121,920
134,035
241,080
35,891
Cash at end of period
113,112
113,112
121,920
134,035
241,080
Free cash flow
Operating cash flow
-192,231
-192,231
-5,853
-124,982
-67,881
Capital expenditure
-12,381
-12,381
-10,206
-13,244
-17,502
Free cash flow
-204,612
-204,612
-16,059
-138,226
-85,383